KYTX compared with SVRA: revenue, margins and what each company keeps, and the suppliers and customers both name

KYTXKyverna Therapeutics, Inc.

Mkt capRevenueRevenue

SVRASavara Inc

Mkt capRevenueRevenue

Compare

KYTXKyverna Therapeutics, Inc.

SVRASavara Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

KYTX, solidSVRA, dashed

Supply-chain overlap

Revenue flow

KYTX: latest quarter not drawable. SVRA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KYTX 3

—Minaris Advanced Therapiesunlistedsupplier

—National Institutes of Healthunlistedsupplier

—Oxford Biomedica (UK)unlistedsupplier

Shared 0

No shared counterparties.

Only SVRA 7

—FUJIFILM Diosynth Biotechnologiesunlistedsupplier

—GEMA Biotechunlistedsupplier

—Parexelunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

PARI Pharma GmbH

unlistedsupplier

3 more · SVRA chain ›

KYTXKyverna Therapeutics, Inc.

5.65▼−3.46%· post 5.65

Mkt cap$350.7M

SVRASavara Inc

4.83▼−2.53%· post 4.83

ClosedOct 30 '26

Mkt cap$990.3M

Compare

ClosedOct 30 '26

KYTXKyverna Therapeutics, Inc.

SVRASavara Inc

5.65▼−3.46%post 5.65

Price

4.83▼−2.53%post 4.83

$350.7M

Mkt cap

$990.3M

KYTX5.65▼−3.46%vsSVRA4.83▼−2.53%ClosedOct 30 '26